BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34762934)

  • 1. Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease.
    Wilkinson AL; John AE; Barrett JW; Gower E; Morrison VS; Man Y; Pun KT; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Fisher AJ; Procopiou PA; Hatley RJD; Barrett TN; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ
    Eur J Pharmacol; 2021 Dec; 913():174618. PubMed ID: 34762934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the
    Roper JA; Wilkinson AL; Gower E; Slack RJ
    J Pharmacol Exp Ther; 2021 Feb; 376(2):273-280. PubMed ID: 33318076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of a novel, high affinity and selective αvβ6 integrin RGD-mimetic radioligand.
    Hall ER; Bibby LI; Slack RJ
    Biochem Pharmacol; 2016 Oct; 117():88-96. PubMed ID: 27501918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis.
    John AE; Graves RH; Pun KT; Vitulli G; Forty EJ; Mercer PF; Morrell JL; Barrett JW; Rogers RF; Hafeji M; Bibby LI; Gower E; Morrison VS; Man Y; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Le J; Flint DJ; Pyne S; Habgood A; Organ LA; Joseph C; Edwards-Pritchard RC; Maher TM; Fisher AJ; Gudmann NS; Leeming DJ; Chambers RC; Lukey PT; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ
    Nat Commun; 2020 Sep; 11(1):4659. PubMed ID: 32938936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of α
    Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
    Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation.
    Jolly L; Stavrou A; Vanderstoken G; Meliopoulos VA; Habgood A; Tatler AL; Porte J; Knox A; Weinreb P; Violette S; Hussell T; Kolb M; Stampfli MR; Schultz-Cherry S; Jenkins G
    J Biol Chem; 2014 Dec; 289(51):35246-63. PubMed ID: 25339175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis.
    Madala SK; Korfhagen TR; Schmidt S; Davidson C; Edukulla R; Ikegami M; Violette SM; Weinreb PH; Sheppard D; Hardie WD
    Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L726-35. PubMed ID: 24508732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis.
    Tatler AL; Goodwin AT; Gbolahan O; Saini G; Porte J; John AE; Clifford RL; Violette SM; Weinreb PH; Parfrey H; Wolters PJ; Gauldie J; Kolb M; Jenkins G
    PLoS One; 2016; 11(8):e0158047. PubMed ID: 27494713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Characterization of the αvβ6 Integrin Binding and Internalization Kinetics of the Foot-and-Mouth Disease Virus Derived Peptide A20FMDV2.
    Slack RJ; Hafeji M; Rogers R; Ludbrook SB; Marshall JF; Flint DJ; Pyne S; Denyer JC
    Pharmacology; 2016; 97(3-4):114-25. PubMed ID: 26734728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts.
    Sheppard D
    Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S21-3. PubMed ID: 25830829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).
    Xu MY; Porte J; Knox AJ; Weinreb PH; Maher TM; Violette SM; McAnulty RJ; Sheppard D; Jenkins G
    Am J Pathol; 2009 Apr; 174(4):1264-79. PubMed ID: 19147812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes.
    Weinreb PH; Simon KJ; Rayhorn P; Yang WJ; Leone DR; Dolinski BM; Pearse BR; Yokota Y; Kawakatsu H; Atakilit A; Sheppard D; Violette SM
    J Biol Chem; 2004 Apr; 279(17):17875-87. PubMed ID: 14960589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.
    John AE; Luckett JC; Tatler AL; Awais RO; Desai A; Habgood A; Ludbrook S; Blanchard AD; Perkins AC; Jenkins RG; Marshall JF
    J Nucl Med; 2013 Dec; 54(12):2146-52. PubMed ID: 24167080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the True Selectivity Profile of αv Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem.
    Rowedder JE; Ludbrook SB; Slack RJ
    SLAS Discov; 2017 Sep; 22(8):962-973. PubMed ID: 28414923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the RGD Motif-Containing α
    Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
    J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alphavbeta6 integrin in acute biliary fibrosis.
    Wang B; Dolinski BM; Kikuchi N; Leone DR; Peters MG; Weinreb PH; Violette SM; Bissell DM
    Hepatology; 2007 Nov; 46(5):1404-12. PubMed ID: 17924447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
    J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
    Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
    J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms.
    Ganter MT; Roux J; Miyazawa B; Howard M; Frank JA; Su G; Sheppard D; Violette SM; Weinreb PH; Horan GS; Matthay MA; Pittet JF
    Circ Res; 2008 Apr; 102(7):804-12. PubMed ID: 18276918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical quantification of the integrin αvβ6 by [
    Lukey PT; Coello C; Gunn R; Parker C; Wilson FJ; Saleem A; Garman N; Costa M; Kendrick S; Onega M; Kang'ombe AR; Listanco A; Davies J; Ramada-Magalhaes J; Moz S; Fahy WA; Maher TM; Jenkins G; Passchier J; Marshall RP
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):967-979. PubMed ID: 31814068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.